320 related articles for article (PubMed ID: 24083759)
1. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
[TBL] [Abstract][Full Text] [Related]
2. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
3. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
Boström A; Lindman H; Swartling C; Berne B; Bergh J
Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
[TBL] [Abstract][Full Text] [Related]
4. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study.
Ulff E; Maroti M; Serup J; Nilsson M; Falkmer U
Radiother Oncol; 2017 Jan; 122(1):50-53. PubMed ID: 27913066
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of an aloe vera, chamomile, and thyme cosmetic cream for the prophylaxis and treatment of mild dermatitis induced by radiation therapy in breast cancer patients: a controlled clinical trial (Alantel Trials).
Jimenez-Garcia C; Perula-de Torres LA; Villegas-Becerril E; Muñoz-Gavilan JJ; Espinosa-Calvo M; Montes-Redondo G; Romero-Rodriguez E;
Trials; 2024 Jan; 25(1):84. PubMed ID: 38273379
[TBL] [Abstract][Full Text] [Related]
7. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
[TBL] [Abstract][Full Text] [Related]
8. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?
Röper B; Kaisig D; Auer F; Mergen E; Molls M
Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of EGF-based cream for the prevention of radiotherapy-induced skin injury: results from a multicenter observational study.
Kang HC; Ahn SD; Choi DH; Kang MK; Chung WK; Wu HG
Radiat Oncol J; 2014 Sep; 32(3):156-62. PubMed ID: 25324987
[TBL] [Abstract][Full Text] [Related]
10. Prospective Study of Breast Radiation Dermatitis.
Drost L; Li N; Vesprini D; Sangha A; Lee J; Leung E; Rakovitch E; Yee C; Chow E; Ruschin M
Clin Breast Cancer; 2018 Oct; 18(5):e789-e795. PubMed ID: 29622382
[TBL] [Abstract][Full Text] [Related]
11. Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy: A Pilot Study.
Fenton-Kerimian M; Cartwright F; Peat E; Florentino R; Maisonet O; Budin W; Rolnitzky L; Formenti S
Clin J Oncol Nurs; 2015 Aug; 19(4):451-5. PubMed ID: 26207710
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
[TBL] [Abstract][Full Text] [Related]
13. Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial.
Ben-David MA; Elkayam R; Gelernter I; Pfeffer RM
Isr Med Assoc J; 2016; 18(3-4):188-92. PubMed ID: 27228641
[TBL] [Abstract][Full Text] [Related]
14. Retrospective study of radiotherapy-induced skin reactions in breast cancer patients: reduced incidence of moist desquamation with a hydroactive colloid gel versus dexpanthenol.
Censabella S; Claes S; Orlandini M; Braekers R; Thijs H; Bulens P
Eur J Oncol Nurs; 2014 Oct; 18(5):499-504. PubMed ID: 24877859
[TBL] [Abstract][Full Text] [Related]
15. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Acceptability of a Moisturizing Cream and a Barrier Cream During Radiation Therapy for Breast Cancer in the Tropics: A Randomized Controlled Trial.
Laffin N; Smyth W; Heyer E; Fasugba O; Abernethy G; Gardner A
Cancer Nurs; 2015; 38(3):205-14. PubMed ID: 24945268
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind trial on the use of 1% hydrocortisone cream for the prevention of acute radiation dermatitis.
Meghrajani CF; Co HS; Arcillas JG; Maaño CC; Cupino NA
Expert Rev Clin Pharmacol; 2016; 9(3):483-91. PubMed ID: 26619355
[TBL] [Abstract][Full Text] [Related]
19. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
[TBL] [Abstract][Full Text] [Related]
20. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
